Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000425589 | SCV000514805 | likely benign | not specified | 2016-03-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000580331 | SCV000686571 | likely benign | Hereditary cancer-predisposing syndrome | 2015-12-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000580331 | SCV004849306 | uncertain significance | Hereditary cancer-predisposing syndrome | 2015-06-30 | criteria provided, single submitter | clinical testing | The c.*11C>T alteration is located in the 3' untranslated region (3'UTR) of the STK11 gene. This alteration consists of a deletion of 1 nucleotides after the last coding exon of the STK11 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Center for Genomic Medicine, |
RCV000425589 | SCV005089923 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing |